CD8A and neoplasm: While effective at priming tumor-specific CD8+ T-cell responses, optimal immunity towards an antigen often requires multiple antigenic encounters20 and Ad5.F35 is expected to induce vector-specific antibodies upon vaccination, limiting the efficacy of repeated immunization.